LIG3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.919400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.872200E-01
Normal-vs-Stage2
7.651800E-01
Normal-vs-Stage3
4.396200E-01
Normal-vs-Stage4
5.923000E-01
Stage1-vs-Stage2
6.888400E-01
Stage1-vs-Stage3
3.104600E-01
Stage1-vs-Stage4
4.996800E-01
Stage2-vs-Stage3
3.615000E-01
Stage2-vs-Stage4
3.187200E-01
Stage3-vs-Stage4
2.190800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.159000E-01
Normal-vs-AfricanAmerican
3.814400E-01
Normal-vs-Asian
9.225400E-01
Caucasian-vs-AfricanAmerican
5.207700E-02
Caucasian-vs-Asian
5.435200E-01
AfricanAmerican-vs-Asian
4.960200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.184000E-01
Normal-vs-Female
8.908800E-01
Male-vs-Female
4.492400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.833400E-01
Normal-vs-Age(41-60Yrs)
9.581600E-01
Normal-vs-Age(61-80Yrs)
6.871600E-01
Normal-vs-Age(81-100Yrs)
8.545600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.082600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.570800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.274000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.053570E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.310200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.036400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.581800E-01
Normal-vs-Daily Drinker
5.059800E-01
Normal-vs-Weekly Drinker
9.369800E-01
Normal-vs-Occasional Drinker
8.598600E-01
Normal-vs-Social Drinker
6.646200E-01
Non Drinker-vs-Daily Drinker
9.305200E-01
Non Drinker-vs-Weekly Drinker
1.530980E-01
Non Drinker-vs-Occasional Drinker
1.436010E-01
Non Drinker-vs-Social Drinker
4.345800E-02
Daily Drinker-vs-Weekly Drinker
2.804600E-01
Daily Drinker-vs-Occasional Drinker
2.724600E-01
Daily Drinker-vs-Social Drinker
5.463900E-02
Weekly Drinker-vs-Occasional Drinker
8.924000E-01
Weekly Drinker-vs-Social Drinker
3.640200E-01
Occasional Drinker-vs-Social Drinker
2.505800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.620960E-01
Normal-vs-Grade 2
9.910500E-02
Normal-vs-Grade 3
4.173900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.225200E-01
Grade 1-vs-Grade 3
9.947000E-01
Grade 1-vs-Grade 4
1.620960E-01
Grade 2-vs-Grade 3
4.086000E-01
Grade 2-vs-Grade 4
9.910500E-02
Grade 3-vs-Grade 4
4.173900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.555400E-01
Normal-vs-NonDiabetic
8.044800E-01
Diabetic-vs-NonDiabetic
3.049800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.220800E-01
Normal-vs-NoPancreatitis
6.954200E-01
Pancreatitis-vs-NoPancreatitis
3.374600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.409400E-01
Normal-vs-N1
7.422200E-01
N0-vs-N1
6.723400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.072200E-01
Normal-vs-TP53-NonMutant
8.347000E-01
TP53-Mutant-vs-TP53-NonMutant
2.762600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
